KLI

검색

Ulsan Univ. Repository

Browsing by Keyword : Pembrolizumab

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

or enter first few letters:

Sort by:
In order:
Results/Page
Etal:

Showing results 1 to 9 of 9

1 Article A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer Eo Jin Kim ; Yong-Hee Cho ; Dong Ha Kim ; et al 2022
2 Article Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma 2021
3 Article Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma 2023
4 Article Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response 강준호 ; 김규표 ; 김기훈 ; et al 2020
5 Article Immune checkpoint inhibitors with chemotherapy for primary advanced mismatch repair-deficient endometrial cancer: A cost-effectiveness analysis 2023
6 Article Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial 류백렬 ; Chao Y. ; Chen E. ; et al 2021
7 Article Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164 2023
8 Article Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial Charles S Fuchs ; Mustafa Özgüroğlu ; Yung-Jue Bang ; et al 2022
9 Article Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors Jwa Hoon Kim ; Bokyung Ahn ; Seung-Mo Hong ; et al 2022

OAK Ulsan Univ. Repository was built as a OAK to the National Central Library.